|
Prediction of outcomes for deep brain stimulation using multimodal MRI |
1K23NS121630-01A1 |
|
NINDS |
2022 |
|
Early post-stroke biomarkers for motor rehabilitation outcomes |
1K23NS121635-01A1 |
|
NINDS |
2022 |
|
Concussion and Attention-Deficit/Hyperactivity Disorder: Investigating the relationship between cognitive outcome, prescription stimulants, and functional MRI biomarkers in the ABCD study. |
1K23NS123345-01A1 |
|
NINDS |
2022 |
|
Enhancing Cognitive Resilience In Parkinsons Disease: Role Of Antiaging Protein Klotho |
1K23NS123506-01A1 |
|
NINDS |
2022 |
|
Mechanisms of Gait and Balance Impairment in Progressive Supranuclear Palsy |
1K23NS124688-01A1 |
|
NINDS |
2022 |
|
The structural underpinnings of disinhibition in dystonia |
1K23NS124978-01A1 |
|
NINDS |
2022 |
|
Efficacy of a Single-Session Telehealth-Based Behavioral Intervention for Chronic Migraines |
1K23NS125004-01 |
|
NINDS |
2022 |
|
Cerebellar cholinergic connections as a biomarker of dementia and gait impairment in Parkinson disease |
1K23NS125107-01 |
|
NINDS |
2022 |
|
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2 |
1K23NS125110-01A1 |
|
NINDS |
2022 |
|
Comprehensive Deep Phenotyping and Multi-omics to Develop Clinical and Molecular Biomarkers for MeCP2-related Diseases |
1K23NS125126-01A1 |
|
NINDS |
2022 |